The Marijuana and Cannabinoids: A Neuroscience Research Summit was
convened by the National Institutes of Health (NIH). The Summit
focused on the neurological and psychiatric effects of marijuana,
other cannabinoids, and the endocannabinoid system. Both the adverse
and the potential therapeutic effects of the cannabinoid system were
discussed. The goal of the summit was to ensure evidence-based information
is available to inform practice and policy, particularly
important at this time given the rapidly shifting landscape
regarding the recreational and medicinal use of marijuana.
The meeting was sponsored by several NIH Institutes and Centers: the National Institute on Drug Abuse (NIDA); the National Institute on Alcohol Abuse and Alcoholism (NIAAA); the National Center for Complementary and Integrative Health (NCCIH); the National Institute of Mental Health (NIMH); and the National Institute of Neurological Disorders and Stroke (NINDS).
The event was held on March 22-23, 2016 at the Natcher Conference Center on the NIH campus in Bethesda, Maryland.
During the Marijuana and Cannabinoids: A Neuroscience Research Summit, scientists from across the country presented their research and answered audience questions from on site and from Twitter using #MJNeuroSummit. Check out the Storify, with the Twitter highlights, here: https://storify.com/NIDAnews/nida-hosts-marijuana-neuroscience-research-summit.
The meeting summary is available here.
NIH Cannabinoid Research Portfolio
Independently Funded Research